Brief: Elanco’s Credelio Gets First FDA Emergency Use Nod Against New World Screwworm in Dogs
24/10/2025 22:10
Oct 24 (Reuters) - Elanco Animal Health Inc ELAN.N: ELANCO'S CREDELIO™ (LOTILANER) RECEIVES FIRST EVER FDA EMERGENCY USE AUTHORIZATION (EUA) AGAINST NEW WORLD SCREWWORM (NWS) IN DOGS Source text: ID:nPncgCDhja Further company coverage: ELAN.N ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Elanco Animal Health Incorporated
See all newsBrief: Elanco Animal Health Appoints Jamie Preston As Chief People Officer
U.S. STOCKS ON THE MOVE-Walt Disney, Alphabet, Kraft Heinz
U.S. STOCKS ON THE MOVE-Wynn Resorts, Griffon, Kratos Defense, Amgen
Elanco Animal Health Incorporated reports results for the quarter ended June 30 - Earnings Summary
U.S. STOCKS ON THE MOVE-Cencora, Charles River, Twist Bioscience